Toxicities | Experimental group N = 21 (%) | Control group N = 21 (%) | ||||
---|---|---|---|---|---|---|
SCPRT | NCT | NCRT | ||||
Grade 1–2 | Grade 3–4 | Grade 1–2 | Grade 3–4 | Grade 1–2 | Grade 3–4 | |
Hematological | ||||||
Total | 6 (28.6) | 0 | 14 (66.7) | 2 (9.5) | 10 (47.6) | 1 (4.8) |
Leukopenia | 6 (28.6) | 0 | 14 (66.7) | 1 (4.8) | 10 (47.6) | 1 (4.8) |
Thrombocytopenia | 0 | 0 | 0 | 1 (4.8) | 0 | 0 |
Neutropenia | 0 | 0 | 3 (14.3) | 0 | 1 (4.8) | 0 |
Anemia | 2 (9.5) | 0 | 2 (9.5) | 0 | 3 (14.3) | 0 |
Non-Hematological | ||||||
Total | 12 (57.1) | 4 (19.0) | 14 (66.7) | 2 (9.5) | 16 (76.2) | 3 (14.3) |
Fatigue | 3 (14.3) | 0 | 3 (14.3) | 0 | 7 (33.3) | 0 |
Bleeding | 6 (28.6) | 0 | 2 (9.5) | 0 | 7 (33.3) | 0 |
Diarrhea | 7 (33.3) | 2 (9.5) | 1 (4.8) | 0 | 4 (19.0) | 3 (14.3) |
Abdominal distension | 1 (4.8) | 1 (4.8) | 1 (4.8) | 0 | 0 | 0 |
Anorexia | 2 (9.5) | 0 | 10 (47.6) | 0 | 1 (4.8) | 0 |
Nausea | 3 (14.3) | 0 | 10 (47.6) | 1 (4.8) | 2 (9.5) | 0 |
Vomiting | 1 (4.8) | 0 | 7 (33.3) | 1 (4.8) | 0 | 0 |
Pain | 8 (38.1) | 4 (19.0) | 3 (14.3) | 1 (4.8) | 13 (61.9) | 1 (4.8) |
Dermatitis | 7 (33.3) | 1 (4.8) | 1 (4.8) | 0 | 9 (42.9) | 1 (4.8) |